S. Harada

发表

Bone Morphogenetic Protein Type IA Receptor Signaling Regulates Postnatal Osteoblast Function and Bone Remodeling*

R. Behringer, Y. Mishina, M. Amling, 2004, Journal of Biological Chemistry.

Control of osteoblast function and regulation of bone mass

Gideon A. Rodan, G. Rodan, S. Harada, 2003, Nature.

Gene expression analyses in cynomolgus monkeys provides mechanistic insight into high-density lipoprotein-cholesterol reduction by androgens in primates.

P. Hodor, C. Johnson, D. Holder, 2008, Endocrinology.

Identification of Genetic Pathways Activated by the Androgen Receptor during the Induction of Proliferation in the Ventral Prostate Gland*

D. Gerhold, P. Hodor, D. Kimmel, 2004, Journal of Biological Chemistry.

Expression and regulation of vascular endothelial growth factor in osteoblasts.

G. Rodan, S. Harada, S. Rodan, 1995, Clinical orthopaedics and related research.

Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity.

G. Rodan, S. Harada, M. Machwate, 2006, Prostaglandins, leukotrienes, and essential fatty acids.

The Missing Bone

G. Rodan, S. Harada, 1997, Cell.

Identification of Anabolic Selective Androgen Receptor Modulators with Reduced Activities in Reproductive Tissues and Sebaceous Glands

D. Kimmel, G. Rodan, D. Towler, 2009, The Journal of Biological Chemistry.

Discovery of the Selective Androgen Receptor Modulator MK-0773 Using a Rational Development Strategy Based on Differential Transcriptional Requirements for Androgenic Anabolism Versus Reproductive Physiology*

P. Hodor, C. Leu, D. Kimmel, 2010, The Journal of Biological Chemistry.

Stimulation of Mouse Osteopontin Promoter by v-Src Is Mediated by a CCAAT Box-binding Factor*

G. Rodan, D. Denhardt, S. Harada, 1996, The Journal of Biological Chemistry.

Expression of the prostaglandin E2 (PGE2) receptor subtype EP4 and its regulation by PGE2 in osteoblastic cell lines and adult rat bone tissue1

G. Rodan, M. Abramovitz, S. Harada, 2001 .

Expression of the prostaglandin E(2) (PGE(2)) receptor subtype EP(4) and its regulation by PGE(2) in osteoblastic cell lines and adult rat bone tissue.

G. Rodan, M. Abramovitz, S. Harada, 2001, Bone.

Characterization of retinoic acid- and cell-dependent sequences which regulate zif268 gene expression in osteoblastic cells.

L. Suva, G. Rodan, D. Towler, 1994, Molecular endocrinology.

Anabolic Steroid Effects on Bone in Women

G. Rodan, S. Harada, A. Schmidt, 2002 .

The role of prostaglandins in bone formation.

G. Rodan, S. Harada, R. Balena, 1995, Connective tissue research.

Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts.

S. Rodan, G. Rodan, J. Nagy, 1994, The Journal of clinical investigation.

Receptor Tyrosine Kinases Inhibit Bone Morphogenetic Protein‐Smad Responsive Promoter Activity and Differentiation of Murine MC3T3‐E1 Osteoblast‐like Cells

K. Miyazono, G. Rodan, Y. Takeuchi, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Androgenic induction of growth and differentiation in the rodent uterus involves the modulation of estrogen-regulated genetic pathways.

D. Gerhold, D. Kimmel, L. Freedman, 2005, Endocrinology.

The LATS2/KPM tumor suppressor is a negative regulator of the androgen receptor.

G. Rodan, L. Freedman, S. Harada, 2004, Molecular endocrinology.

Targeted overexpression of androgen receptor in osteoblasts: unexpected complex bone phenotype in growing animals.

K. Jepsen, M. Gentile, V. Kasparcova, 2004, Endocrinology.

Direct agonist/antagonist functions of dehydroepiandrosterone.

H. Wilkinson, L. Freedman, S. Harada, 2005, Endocrinology.

Sphingosine kinase mediates cyclic AMP suppression of apoptosis in rat periosteal cells.

S. Rodan, G. Rodan, S. Harada, 1998, Molecular pharmacology.

Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2).

C. Leu, R. Young, S. Rodan, 2001, Molecular pharmacology.

Osteogenic protein-1 up-regulation of the collagen X promoter activity is mediated by a MEF-2-like sequence and requires an adjacent AP-1 sequence.

J. Aubin, G. Rodan, S. Harada, 1997, Molecular endocrinology.

Sox8 is a critical regulator of adult Sertoli cell function and male fertility.

S. Takada, Y. Mishina, D. Wilhelm, 2008, Developmental biology.

Possible requirement of serum progression factors for transformation of BALB/c 3T3 fibroblasts by v‐Ras p21

I. Nishimoto, S. Harada, 1991, FEBS letters.

Suppression of Adjuvant‐Induced Arthritic Bone Destruction by Cyclooxygenase‐2 Selective Agents With and Without Inhibitory Potency Against Carbonic Anhydrase II

Kozo Nakamura, T. Takato, T. Ogasawara, 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A Regulatory Circuit Mediating Convergence between Nurr1 Transcriptional Regulation and Wnt Signaling

C. Leu, S. Kato, L. Freedman, 2007, Molecular and Cellular Biology.

Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2).

C. Leu, S. Rodan, G. Rodan, 2001, Molecular pharmacology.

Gene expression analyses in cynomolgus monkeys provides mechanistic insight into high-density lipoprotein-cholesterol reduction by androgens in primates.

P. Hodor, D. Holder, S. Harada, 2008, Endocrinology.